Pharmafile Logo
Pharmafocus logo
Advanced Search

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …

Appointment
e

Teva sees modest growth as US sales fall

November 3, 2011
Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

News

Doctors decry cost-cutting in HIV treatment

November 2, 2011
Sales and Marketing HIV, NHS, Reyataz

Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …

News

Richard Daniell appointed as managing director of Teva UK

November 2, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …

Appointment
Sanofi HQ pic

Sanofi to become world’s biggest drug maker

November 2, 2011
Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …

News
pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

News
picture_2

Lundbeck appoints two new R&D vice presidents

November 1, 2011
Research and Development Lundbeck, R&D

Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …

Appointment
Obama image

Obama takes action to curb medicine shortages

November 1, 2011
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs

US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …

News
Lonza image

Lonza sees continued recovery in third quarter

November 1, 2011
Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production

Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …

News
Pradaxa

NICE U-turn on Boehringer’s Pradaxa

November 1, 2011
Sales and Marketing NICE, Pradaxa

NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …

News

Shadow Commissioning Board goes live

October 31, 2011
Medical Communications Commissioning Board, DH, NHS

The NHS Commissioning Board, the new central and powerful committee that will co-ordinate the health service in England, has been …

News

UK researchers claim advance in chiral manufacturing

October 31, 2011
Manufacturing and Production Cambridge University, chiral manufacturig, chiral manufacturing

Researchers from the UK says a new technique which uses metal surfaces as templates to make drug compounds with specific …

News
Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …

Feature

Contract research news in brief

October 31, 2011
Manufacturing and Production, Research and Development CRO, manufacturing and production

PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …

News
Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011
Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …

News
peter_maag

Carsten Schroeder appointed interim president of Novartis Diagnostics

October 31, 2011
Sales and Marketing Novartis

Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …

Appointment
Swiss protest image

Novartis job cuts protest

October 31, 2011
Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production

Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …

News

Core products boost Merck’s results

October 31, 2011
Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis

Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment.  Worldwide sales …

News

Brilique gains NICE approval

October 31, 2011
Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel

AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …

News

Boehringer agrees Pradaxa kidney function warning

October 30, 2011
Sales and Marketing AF, EMA, Pradaxa, renal function

Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026